JESSICA WIX-FAULKNER: Open Payments
NPI 1881161701 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 40 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $578 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $205 |
| ABBVIE INC. | 14 | $189 |
| Boston Scientific Corporation | 1 | $183 |
| Novo Nordisk Inc | 4 | $75 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| Amgen Inc. | 3 | $60 |
| Dexcom, Inc. | 2 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $29 |
| PFIZER INC. | 1 | $29 |
Products named: Axios, AIRSUPRA, LINZESS, CREON, OTEZLA, Dexcom G6 Transmitter, Rybelsus, CAPVAXIVE.
Industry payments across CA — which companies pay providers there.
